Peripheral blood myeloma cells as a prognostic factor for survival in patients with new, untreated multiple myeloma.

被引：0
|
作者：
Witzig, TE [1 ]
Gertz, MA [1 ]
Lust, JA [1 ]
Kyle, RA [1 ]
OFallon, WM [1 ]
Greipp, PR [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [1] Circulating proteasome level is an independent prognostic factor for survival in patients with multiple myeloma.
    Jakob, C
    Egerer, K
    Feist, E
    Zavrski, I
    Eucker, J
    Heider, U
    Burmester, G
    Possinger, K
    Kloetzel, PM
    Sezer, O
    [J]. BLOOD, 2004, 104 (11) : 415A - 415A
  • [2] Statins use and peripheral blood progenitor cells mobilization in patients with multiple myeloma.
    Voutsadakis, Ioannis
    Stravodimou, Athina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] CD200 is a new prognostic factor in multiple myeloma.
    Moreaux, Jerome
    Hose, Dirk
    Reme, Thierry X.
    Jourdan, Eric
    Hundemer, Michael
    Eric, Legouffe
    Moine, Philippe
    Bourin, Philippe
    Moos, Marion
    Corre, Jill
    Mölher, Thomas
    DeVos, John
    Rossi, Jean-Francois
    Goldschmidt, Hartmut
    Klein, Bernard
    [J]. BLOOD, 2006, 108 (11) : 338B - 338B
  • [4] Advanced age is not an adverse prognostic factor for patients with multiple myeloma.
    Dimopoulos, M
    Pouli, A
    Zervas, K
    Gika, D
    Repousis, P
    Mitsouli, C
    Grigoraki, V
    Anagnostopoulos, N
    Stamatellou, M
    Symeonidis, A
    Maniatis, A
    [J]. BLOOD, 2002, 100 (11) : 600A - 600A
  • [5] Peripheral blood progenitor cell autografting in patients with multiple myeloma.
    Goldschmidt, H
    Hegenbart, U
    Egerer, G
    Fruhauf, S
    Voso, MT
    Hohaus, S
    Wannenmacher, M
    Haas, R
    [J]. BLOOD, 1997, 90 (10) : 1707 - 1707
  • [6] Circulating endothelial cells are prognostic in multiple myeloma.
    Jin, Z
    Hong, Z
    Smith, ELP
    Gölcü, D
    Weiss, GJ
    Berenson, JR
    Moezi, M
    Aloba, C
    Batuman, OA
    [J]. BLOOD, 2002, 100 (11) : 394A - 394A
  • [7] Prognostic factors in multiple myeloma.: A multivariate analysis of presenting features in 394 patients with multiple myeloma.
    Turesson, I
    Abildgaard, N
    Dahl, IM
    Holmberg, E
    Hjorth, M
    Nielsen, JL
    Oden, A
    Seidel, C
    Waage, A
    Westin, J
    Wislöff, F
    [J]. BLOOD, 1998, 92 (10) : 271B - 271B
  • [8] Evaluation of prognostic factors in patients with multiple myeloma.
    Hungria, VTM
    Gomez, M
    Moraes, JC
    Barros, JC
    Chiattone, CS
    [J]. BLOOD, 1995, 86 (10) : 3329 - 3329
  • [9] Bortezomib alters peripheral blood lymphocyte subsets in patients with multiple myeloma.
    Uy, GL
    Holt, MS
    Fisher, NM
    Devine, SM
    Tomasson, MH
    DiPersio, JF
    Vij, R
    [J]. BLOOD, 2005, 106 (11) : 672A - 672A
  • [10] Autologous transplantation in multiple myeloma. Is age a prognostic factor?
    Milone, G
    Kusminsky, G
    Orlando, S
    Koziner, B
    Milone, J
    Basso, A
    Garcia, JJ
    Bullorsky, E
    Canepa, C
    Robinson, A
    Cerutti, L
    Milovic, V
    Lastiri, F
    Bordone, J
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S103 - S104
12345